title: Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D004345:Drug Industry / Q000639:trends; D006801:Humans; D008565:Membrane Proteins / Q000187:drug effects; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D009186:Myelin Sheath / Q000187:drug effects* / Q000502:physiology*; D009416:Nerve Regeneration; D009419:Nerve Tissue Proteins / Q000187:drug effects
chemical_list: C482293:LINGO1 protein, human; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins